FDA Approves Cannabidiol for Tuberous Sclerosis Complex FDA Approves Cannabidiol for Tuberous Sclerosis Complex
The US Food and Drug Administration has expanded its approval for cannabidiol (Epidiolex) oral solution to also treat seizures in tuberous sclerosis complex for patients aged 1 year and older.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 4, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 3, 2020 Category: Drugs & Pharmacology Source Type: news

New drug pathway linked with tuberous sclerosis
(Boston Children's Hospital) Researchers in the Translational Neuroscience Center have discovered that the heat shock protein cascade may represent druggable targets for tuberous sclerosis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2020 Category: International Medicine & Public Health Source Type: news

Signs and Symptoms of Tuberous Sclerosis
What Are the Signs and Symptoms of Tuberous Sclerosis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 9, 2020 Category: General Medicine Source Type: news

NeuroPace Removes Barrier for Epilepsy Treatment Through FDA Nod
NeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based company’s RNS System treats patients living with seizures that do not respond to medication and first landed a PMA in November of 2013. In a release, the company said individuals with focal onset seizures that also have brain anomalies that require monitoring, such as tuberous sclerosis, brain tumors or multiple sclerosis, as well as those with non-brain MRI requirements, can now be offered the RNS System as a treatment option. The company added this will also a...
Source: MDDI - March 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Regulatory and Compliance Source Type: news

Getting Quality Autism Therapy From Thousands of Miles Away
TUESDAY, Feb. 25, 2020 -- By the time he was 7 months old, John Michael Crawford had been diagnosed with a rare genetic disorder called tuberous sclerosis, associated with a high risk of developmental delays, including autism. Early intervention... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 25, 2020 Category: General Medicine Source Type: news

Purified CBD May Help Treat Drug-Resistant Epilepsy
TUESDAY, Dec. 10, 2019 -- Among patients with tuberous sclerosis complex (TSC), the reduction in the frequency of TSC-associated seizures was greater in those receiving a purified version of cannabidiol (CBD) than in those receiving placebo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 10, 2019 Category: Pharmaceuticals Source Type: news

Cannabis Drug Promising for Seizures Linked to Tuberous Sclerosis Cannabis Drug Promising for Seizures Linked to Tuberous Sclerosis
A cannabidiol-derived drug approved for the treatment of Dravet and Lennox-Gastaut syndromes also reduces seizures in patients with tuberous sclerosis complex.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 9, 2019 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

CBD Medicine May Help Ease Another Form of Seizure
SATURDAY, Dec. 7, 2019 -- Prescription-grade CBD may help control hard-to-treat seizures caused by a rare genetic disorder, a preliminary study suggests. The study involved 224 patients with tuberous sclerosis complex (TSC) -- a genetic condition... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2019 Category: General Medicine Source Type: news

UM Medicine launches treatment centers for adult neurodevelopmental issues
(University of Maryland School of Medicine) The University of Maryland School of Medicine (UMSOM), University of Maryland Medical Center (UMMC), and the Tuberous Sclerosis Alliance (TS Alliance) have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2019 Category: International Medicine & Public Health Source Type: news

UCLA scientists honored with Presidential Early Career Awards
Two UCLA scientists are recipients of the 2019  Presidential Early Career Award for Scientists and Engineers for their “exceptional promise for leadership in science and technology.”The PECASE is the federal government ’s highest honor recognizing scientists for their contributions to science, technology, engineering and mathematics education. It also recognizes community service as demonstrated by scientific leadership, public education and community outreach.The White House Office of Science and Technology Policy coordinates the awards with participating departments and agencies. The awards ce...
Source: UCLA Newsroom: Health Sciences - July 12, 2019 Category: Universities & Medical Training Source Type: news

What Causes Macrocephaly?
Discussion “Macrocephaly is defined as [an occipitofrontal circumference or head circumference, OFC ] of> 2 standard deviations above the mean or above the 97th percentage for a given age, and gender, or when serial measurement shows progressive enlargement, crossing of one or more major percentiles, or when there is an increase in OFC> 2 cm/month in the first 6 months of life.” Megalencephaly is enlargement of the brain parenchyma. The OFC should be measured using a non-elastic tape which surrounds the head along the line of the glabella and posterior occipital protrusion. There are ethnic differences f...
Source: PediatricEducation.org - May 20, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

GW Pharma's epilepsy drug meets main goal in late-stage trial
GW Pharmaceuticals Plc said on Monday its drug Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis complex during a late-stage trial. (Source: Reuters: Health)
Source: Reuters: Health - May 6, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Terminally Ill Boy Exposed to Measles
The 7-year-old has a condition called tuberous sclerosis. His mother said doctors told her that her son was exposed to measles by an unvaccinated child who had caught the disease while overseas. (Source: WebMD Health)
Source: WebMD Health - April 4, 2019 Category: Consumer Health News Source Type: news

Two independent mechanisms are involved in tuberous sclerosis
(Baylor College of Medicine) The development of the rare condition called tuberous sclerosis involves mTORC1-dependent and -independent mechanisms. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 7, 2019 Category: Biology Source Type: news

MGH receives $50M gift from founder of Princeton Properties
Massachusetts General Hospital has received its third largest gift in its history, a $50 million donation from James S. and Carol J. Herscot. The funding will go toward a variety of capital projects and to the Center for Children and Adults with Tuberous Sclerosis Complex, which currently bears the Herscot's name. The hospital will also rename an outpatient facility that houses the Herscot Center after the family. “Jim and Carol hav e been among the hospital’s strongest supporters and champions… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 6, 2019 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

MGH receives $50M gift from founder of Princeton Properties
Massachusetts General Hospital has received its third largest gift in its history, a $50 million donation from James S. and Carol J. Herscot. The funding will go toward a variety of capital projects and to the Center for Children and Adults with Tuberous Sclerosis Complex, which currently bears the Herscot's name. The hospital will also rename an outpatient facility that houses the Herscot Center after the family. “Jim and Carol hav e been among the hospital’s strongest supporters and champions… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2019 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
(Boston Children's Hospital) New research in a mouse model suggests that the drug rapamycin can reverse autism-like social deficits -- but only if given early. The study is the first to shed light on the crucial timing of therapy to improve social impairments in a condition associated with autism spectrum disorder. Its findings could help inform future clinical trials in children with tuberous sclerosis complex. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 9, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves First Cannabis-Based Drug
(CNN) — The US Food and Drug Administration approved a cannabis-based drug for the first time, the agency said Monday. Epidiolex was recommended for approval by an advisory committee in April, and the agency had until this week to make a decision. The twice-daily oral solution is approved for use in patients 2 and older to treat two types of epileptic syndromes: Dravet syndrome, a rare genetic dysfunction of the brain that begins in the first year of life, and Lennox-Gastaut syndrome, a form of epilepsy with multiple types of seizures that begin in early childhood, usually between 3 and 5. “This is an important...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cannabis Local TV Marijuana Source Type: news

Topical Rapamycin Effective for TSC-Related Facial Angiofibromas
FRIDAY, June 8, 2018 -- Topical rapamycin seems effective for tuberous sclerosis complex (TSC)-related facial angiofibromas, according to a study published online May 23 in JAMA Dermatology. Mary Kay Koenig, M.D., from The University of Texas Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2018 Category: Pharmaceuticals Source Type: news

Frequent falls and confusion: recurrent hypoglycemia in a patient with tuberous sclerosis complex - Comninos AN, Yang L, Abbara A, Dhillo WS, Bassett JHD, Todd JF.
We describe a case of an insulinoma presenting with falls and confusion in a patient with tuberous sclerosis, demonstratin... (Source: SafetyLit)
Source: SafetyLit - May 14, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Bilateral, Multifocal Renal Masses in a 35-Year-Old Man With a History of Tuberous Sclerosis Complex
A 35-year-old man with a known history of tuberous sclerosis complex was referred to the urology clinic by his primary care physician for consultation regarding bilateral, multifocal renal masses. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2018 Category: Cancer & Oncology Authors: Allan Haynes, Jr, MD Pranav Sharma, MD Tags: Oncology Journal Source Type: news

FDA Approves Afinitor Disperz (everolimus) for Tuberous Sclerosis Complex-Associated Partial-Onset Seizures
April 11, 2018 -- On April 10, 2018, the Food and Drug Administration approved everolimus tablets for oral suspension (Afinitor Disperz, Novartis Pharmaceuticals Corp.) for the adjunctive treatment of adult and pediatric patients aged 2 years and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 12, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis
Everolimus tablets for oral suspension become the first approved therapy specifically indicated for the treatment of partial-onset seizures associated with tuberous sclerosis complex.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Persistence of self-injury, aggression and property destruction in children and adults with tuberous sclerosis complex - Wilde L, Wade K, Eden K, Moss J, de Vries PJ, Oliver C.
BACKGROUND: Individuals with tuberous sclerosis complex (TSC) are at increased risk of developing self-injurious behaviour. The persistence of this deleterious behaviour over years is reported in aetiologically heterogeneous samples to be between 60% and 8... (Source: SafetyLit)
Source: SafetyLit - February 17, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Lab-grown human cerebellar cells yield clues to autism
(Boston Children's Hospital) Increasing evidence has linked autism spectrum disorder (ASD) with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology to create cerebellar cells known as Purkinje cells from patients with tuberous sclerosis complex (TSC), a genetic syndrome that often includes ASD-like features. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2018 Category: International Medicine & Public Health Source Type: news

Code talker: A Q & A with genetic counselor Kira Dies
Your child has just been diagnosed with a rare genetic disorder. Your pediatrician has never heard of the condition and the internet doesn’t offer much information. Where do you turn? Kira Dies, a genetic counselor in the Department of Neurology at Boston Children’s Hospital, helps parents with these hard questions every day. One of about only 4,000 genetic counselors in the country, Dies has been trained in handling both the scientific and emotional sides of genetic disorders. Dies was also the recent winner of the Code Talker Award, presented by Genome Magazine and the National Society of Genetic Counselors (...
Source: Thrive, Children's Hospital Boston - November 17, 2017 Category: Pediatrics Authors: Ellen Greenlaw Tags: Ask the Expert genetic counselor Kira Dies Mustafa Sahin Neurogenetics Program SPG47 tuberous sclerosis complex tuberous sclerosis program Source Type: news

CDMRP:Transforming Healthcare through Innovative and Impactful Research
Kidney Cancer Research (KCRP) has been funded by the CDMRP for many years under various programs including the Peer Reviewed Medical Research Program, Tuberous Sclerosis Complex Research Program, and, most recently, by the Peer Reviewed Cancer Research Program (PRCRP). From FY10 through FY16, the PRCRP invested over $9.8M in kidney cancer research. In FY17 the US Congress directed $10M to kidney cancer research in the DoD appropriation, thus establishing the Kidney Cancer Research Program.10/28/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 28, 2017 Category: Urology & Nephrology Source Type: news

Tuberous Sclerosis Complex (TSC)
Title: Tuberous Sclerosis Complex (TSC)Category: Diseases and ConditionsCreated: 10/17/2017 12:00:00 AMLast Editorial Review: 10/18/2017 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - October 18, 2017 Category: Pediatrics Source Type: news

Study identifies tools to identify patients at risk for autism spectrum disorders
(Cincinnati Children's Hospital Medical Center) A tool intended to detect signs of autism in high-risk infants can be used to help identify and treat patients with tuberous sclerosis complex, a genetic disorder, who most need early intervention. Moreover, they can identify these patients earlier than ever before. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 17, 2017 Category: International Medicine & Public Health Source Type: news

Long-Lasting Effect of Everolimus in Tuberous Sclerosis Long-Lasting Effect of Everolimus in Tuberous Sclerosis
Researchers observe effects that seem to improve the longer the drug is taken in an open-label extension of the phase 2 EXIST-3 trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 11, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Self-injury and aggression in adults with tuberous sclerosis complex: frequency, associated person characteristics, and implications for assessment - Wilde L, Eden K, de Vries P, Moss J, Welham A, Oliver C.
Even though self-injury and aggression are common in tuberous sclerosis complex (TSC), understanding of these behaviours in adults with TSC and intellectual disability (ID) is limited. Little is known about their frequency in comparison to other ID-related... (Source: SafetyLit)
Source: SafetyLit - April 17, 2017 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

New cause of brain defects in tuberous sclerosis complex
A new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex (TSC) has been discovered by researchers. The study suggests new ways to treat some of the neurological symptoms associated with TSC, including autism and epilepsy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2017 Category: Science Source Type: news

Novartis says Votubia receives EU approval for new indication
ZURICH (Reuters) - Novartis has broadened the indications for its Votubia drug, the company said on Tuesday, when the European Union approved its use to treat refractory partial-onset seizures in patients with tuberous sclerosis complex. (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Findings in tuberous sclerosis complex on the role of inflammation and epilepsy
(US Department of Defense Congressionally Directed Medical Research Programs) Dr. Wong focused on ECG treatment in the mice and found that treatment did minimally correct some of the brain tissue abnormalities seen in the mouse model, but, more importantly, there was a small decrease in seizure development and slightly improved survival in these mice. Dr. Wong and his laboratory have provided a proof-of-concept preclinical study suggesting that anti-inflammatory treatment could be a potential therapy for epilepsy in TSC patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2016 Category: Global & Universal Source Type: news

Sirolimus Gel for Tuberous Sclerosis Facial Angiofibromas Sirolimus Gel for Tuberous Sclerosis Facial Angiofibromas
A topical sirolimus gel is safe and effective for treating facial angiofibromas in patients with tuberous sclerosis complex (TSC), Japanese researchers report.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 23, 2016 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

EXIST-3: Everolimus Decreases Seizures in Tuberous Sclerosis EXIST-3: Everolimus Decreases Seizures in Tuberous Sclerosis
Calling the study'ground-breaking,'one expert says the results'nail down'important issues involved in targeting tuberous sclerosis seizures'with a rational, pathophysiological approach. 'Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 10, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Drug reduces seizure frequency in children with tuberous sclerosis complex
(Cincinnati Children's Hospital Medical Center) In an international study, the drug everolimus has been shown to significantly reduce the frequency of seizures in patients with treatment-resistant epilepsy and tuberous sclerosis complex (TSC) -- a genetic disease that causes malformations and tumors in the brain and other vital organs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 6, 2016 Category: Cancer & Oncology Source Type: news

Research note: Yale team provides new insight into intractable epilepsy
One of the major causes of intractable epilepsy is a malformation of brain development that occurs in individuals with focal cortical dysplasia or tuberous sclerosis complex. These malformations are marked by misplaced and abnormally large neurons in focal cortical brain regions. However, a Yale team led by Angelique Bordey and Lawrence S. Hsieh developed a new mouse model of focal cortical malformation that showed neuronal misplacement is not required to trigger seizures. Instead, large misshapen neurons by themselves can generate seizures, according to the study published June 1 in the journal Nature Communications. The ...
Source: Yale Science and Health News - June 2, 2016 Category: Universities & Medical Training Tags: Yale News Source Type: news

Everolimus May Have Activity in Seizure Disorder
(MedPage Today) -- Drug reduced seizure frequency in tuberous sclerosis compared with placebo (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - April 22, 2016 Category: Journals (General) Source Type: news

Everolimus Data for Seizures in Tuberous Sclerosis 'Exciting'Everolimus Data for Seizures in Tuberous Sclerosis 'Exciting'
The new results may open the door to eventually being able to treat epilepsy, not just seizures, researchers say. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 21, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

GW Pharmaceuticals initiates Phase 3 study of Epidiolex for TSC disorder
GW Pharmaceuticals has started a Phase 3 clinical trial of Epidiolex as an adjunctive therapy for treatment of seizures related to tuberous sclerosis complex (TSC), a rare genetic disorder where the most common symptom is epilepsy. (Source: Drug Development Technology)
Source: Drug Development Technology - April 12, 2016 Category: Pharmaceuticals Source Type: news

GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
LONDON, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary ca... Biopharmaceuticals, NeurologyGW Pharmaceuticals, Epidiolex, cannabidiol, Tuberous Sclerosis Complex (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2016 Category: Pharmaceuticals Source Type: news

Cancer study is 'paradigm shift' in cause of tumor formation
A gene that may provide a new source of potential drug targets for tumors that arise in pulmonary tuberous sclerosis complex (TSC) has been found by a pair of investigators. The discovery may change what is known about tumor formation and help to slow or halt tumor growth, therefore having broader implications in cancer research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 17, 2016 Category: Science Source Type: news

Blanket forts, healthy hearts and life: What our families are thankful for
When parents and children first arrive at our front door — no matter why or from where they come — they forever become part of our extended family. On this Thanksgiving, just like the 47 million others who are traveling to see loved ones, we too packed up the car and drove to visit 11 of the families who have stayed with us at Boston Children’s over the years. We wanted to find out what they were most thankful for and what makes this season special to them. Thank you to the families of Ella S., Julian, Ella D., Addison, Callum, Nora, Avery, Jace, Molly, Charlotte, Murphy and Robbie for welcoming us i...
Source: Thrive, Children's Hospital Boston - November 26, 2015 Category: Pediatrics Authors: Jenny Fernandez Tags: All posts Thanksgving Source Type: news

Everolimus Results Improve for SEGA in Tuberous Sclerosis Everolimus Results Improve for SEGA in Tuberous Sclerosis
The EXIST-1 extension trial shows that rates of response to treatment with everolimus improved after 4 years in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 3, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

For children with rare genetic disorder, more extensive epilepsy surgery yields better seizure control
(Wolters Kluwer Health) Children with the genetic disorder tuberous sclerosis complex often need epilepsy surgery for severe, uncontrollable seizures. A new study finds that seizure control is improved for patients undergoing more extensive surgery, reports the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2015 Category: Global & Universal Source Type: news

Management of renal angiomyolipomas in TSC
mTOR inhibition is likely to transform management of tuberous sclerosis complex and the results of landmark trials are being studied to see if the encouraging reductions in tumour size translate into improved outcomes for patients in the long term (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 16, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news

For children with rare genetic disorder, more extensive epilepsy surgery yields better seizure control
Children with the genetic disorder tuberous sclerosis complex (TSC) often need epilepsy surgery for severe, uncontrollable seizures. A new study finds that seizure control is improved for patients undergoing more extensive surgery. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 15, 2015 Category: Science Source Type: news